| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.865 | 0.003 | 0.901 | Bronchodilator | 0.901 0.003 DBMET02956 0.535 0.004 DBMET02959 0.43 0.005 DBMET02960 0.746 0.004 DBMET02961 0.642 0.004 DBMET02963 0.584 0.004 DBMET02957 0.55 0.004 DBMET02958 0.513 0.004 DBMET02962 | DBMET02956 | |
| 0.856 | 0.001 | 0.858 | Beta adrenoreceptor antagonist | 0.858 0.001 DBMET02956 0.136 0.007 DBMET02959 0.137 0.007 DBMET02960 0.522 0.002 DBMET02961 0.283 0.003 DBMET02963 0.167 0.005 DBMET02957 0.145 0.006 DBMET02958 0.156 0.005 DBMET02962 | DBMET02956 | |
| 0.83 | 0.001 | 0.885 | Adrenaline agonist | 0.885 0.001 DBMET02956 0.296 0.004 DBMET02959 0.27 0.004 DBMET02960 0.559 0.002 DBMET02961 0.465 0.002 DBMET02963 0.41 0.003 DBMET02957 0.364 0.003 DBMET02958 0.246 0.005 DBMET02962 | DBMET02956 | |
| 0.767 | 0.001 | 0.863 | Beta adrenoreceptor agonist | 0.863 0.001 DBMET02956 0.142 0.003 DBMET02959 0.126 0.003 DBMET02960 0.413 0.002 DBMET02961 0.351 0.002 DBMET02963 0.318 0.002 DBMET02957 0.239 0.002 DBMET02958 0.093 0.004 DBMET02962 | DBMET02956 | |
| 0.743 | 0.005 | 0.821 | Spasmolytic | 0.754 0.005 DBMET02956 0.789 0.004 DBMET02959 0.638 0.01 DBMET02960 0.688 0.007 DBMET02961 0.626 0.011 DBMET02963 0.821 0.004 DBMET02957 0.813 0.004 DBMET02958 0.361 0.049 DBMET02962 | DBMET02957 | |
| 0.732 | 0.001 | 0.78 | Beta 2 adrenoreceptor antagonist | 0.78 0.001 DBMET02956 0.106 0.007 DBMET02959 0.112 0.007 DBMET02960 0.415 0.002 DBMET02961 0.302 0.003 DBMET02963 0.15 0.004 DBMET02957 0.137 0.005 DBMET02958 0.122 0.006 DBMET02962 | DBMET02956 | |
| 0.682 | 0.001 | 0.792 | Beta 1 adrenoreceptor agonist | 0.792 0.001 DBMET02956 0.039 0.005 DBMET02959 0.037 0.005 DBMET02960 0.258 0.002 DBMET02961 0.118 0.003 DBMET02963 0.091 0.003 DBMET02957 0.062 0.004 DBMET02958 0.045 0.004 DBMET02962 | DBMET02956 | |
| 0.645 | 0.005 | 0.691 | Antiadrenergic | 0.691 0.004 DBMET02956 0.207 0.023 DBMET02959 0.133 0.041 DBMET02960 0.635 0.005 DBMET02961 0.378 0.009 DBMET02963 0.232 0.019 DBMET02957 0.204 0.024 DBMET02958 0.323 0.012 DBMET02962 | DBMET02956 | |
| 0.643 | 0.005 | 0.689 | Adrenaline antagonist | 0.689 0.004 DBMET02956 0.204 0.023 DBMET02959 0.13 0.04 DBMET02960 0.631 0.005 DBMET02961 0.375 0.009 DBMET02963 0.229 0.019 DBMET02957 0.201 0.023 DBMET02958 0.32 0.012 DBMET02962 | DBMET02956 | |
| 0.648 | 0.015 | 0.732 | Antiobesity | 0.717 0.01 DBMET02956 0.597 0.021 DBMET02959 0.401 0.065 DBMET02960 0.732 0.009 DBMET02961 0.692 0.012 DBMET02963 0.66 0.014 DBMET02957 0.633 0.017 DBMET02958 0.659 0.014 DBMET02962 | DBMET02961 | |
| 0.627 | 0.003 | 0.711 | Acetylcholine M1 receptor antagonist | 0.711 0.003 DBMET02956 0.252 0.025 DBMET02959 0.189 0.047 DBMET02960 0.317 0.012 DBMET02961 0.282 0.018 DBMET02963 0.327 0.01 DBMET02957 0.303 0.014 DBMET02958 | DBMET02956 | |
| 0.634 | 0.014 | 0.676 | Toll-Like receptor 7 agonist | 0.676 0.01 DBMET02956 0.508 0.03 DBMET02959 0.302 0.109 DBMET02960 0.551 0.023 DBMET02961 0.565 0.022 DBMET02963 0.555 0.023 DBMET02957 0.526 0.027 DBMET02958 0.369 0.073 DBMET02962 | DBMET02956 | |
| 0.629 | 0.014 | 0.671 | Toll-Like receptor agonist | 0.671 0.01 DBMET02956 0.516 0.029 DBMET02959 0.315 0.102 DBMET02960 0.55 0.023 DBMET02961 0.579 0.02 DBMET02963 0.562 0.022 DBMET02957 0.535 0.026 DBMET02958 0.381 0.068 DBMET02962 | DBMET02956 | |
| 0.583 | 0.008 | 0.619 | Calcium channel L-type activator | 0.605 0.005 DBMET02956 0.506 0.025 DBMET02959 0.418 0.069 DBMET02960 0.619 0.005 DBMET02961 0.526 0.019 DBMET02963 0.514 0.023 DBMET02957 0.528 0.018 DBMET02958 0.567 0.01 DBMET02962 | DBMET02961 | |
| 0.56 | 0.003 | 0.626 | Acetylcholine muscarinic antagonist | 0.626 0.003 DBMET02956 0.176 0.031 DBMET02959 0.14 0.05 DBMET02960 0.261 0.013 DBMET02961 0.236 0.017 DBMET02963 0.274 0.011 DBMET02957 0.226 0.019 DBMET02958 | DBMET02956 | |
| 0.551 | 0.004 | 0.623 | Cholinergic antagonist | 0.623 0.004 DBMET02956 0.14 0.059 DBMET02959 0.102 0.093 DBMET02960 0.227 0.026 DBMET02961 0.182 0.037 DBMET02963 0.223 0.026 DBMET02957 0.178 0.039 DBMET02958 | DBMET02956 | |
| 0.551 | 0.004 | 0.622 | Acetylcholine antagonist | 0.622 0.004 DBMET02956 0.124 0.067 DBMET02959 0.224 0.025 DBMET02961 0.183 0.035 DBMET02963 0.199 0.031 DBMET02957 0.161 0.045 DBMET02958 | DBMET02956 | |
| 0.526 | 0.001 | 0.642 | Beta 2 adrenoreceptor agonist | 0.642 0.001 DBMET02956 0.121 0.004 DBMET02959 0.112 0.004 DBMET02960 0.285 0.001 DBMET02961 0.257 0.002 DBMET02963 0.191 0.002 DBMET02957 0.167 0.003 DBMET02958 0.113 0.004 DBMET02962 | DBMET02956 | |
| 0.519 | 0.001 | 0.65 | Beta 3 adrenoreceptor agonist | 0.65 0.001 DBMET02956 0.015 0.006 DBMET02959 0.013 0.007 DBMET02960 0.285 0.002 DBMET02961 0.076 0.003 DBMET02963 0.067 0.003 DBMET02957 0.038 0.004 DBMET02958 0.028 0.004 DBMET02962 | DBMET02956 | |
| 0.519 | 0.002 | 0.608 | Acetylcholine M3 receptor antagonist | 0.608 0.002 DBMET02956 0.055 0.048 DBMET02959 0.247 0.005 DBMET02961 0.11 0.016 DBMET02963 0.114 0.015 DBMET02957 0.082 0.025 DBMET02958 | DBMET02956 | |
| 0.485 | 0.046 | 0.813 | Transcription factor NF kappa B inhibitor | 0.488 0.046 DBMET02956 0.793 0.013 DBMET02959 0.683 0.022 DBMET02960 0.462 0.051 DBMET02961 0.299 0.094 DBMET02963 0.78 0.014 DBMET02957 0.813 0.012 DBMET02958 | DBMET02958 | |
| 0.398 | 0.004 | 0.457 | Acetylcholine M2 receptor antagonist | 0.457 0.003 DBMET02956 0.094 0.023 DBMET02961 0.059 0.046 DBMET02963 0.06 0.045 DBMET02957 | DBMET02956 | |
| 0.378 | 0.002 | 0.384 | Beta 1 adrenoreceptor antagonist | 0.384 0.002 DBMET02956 0.051 0.045 DBMET02959 0.381 0.002 DBMET02961 0.132 0.006 DBMET02963 0.06 0.035 DBMET02957 0.056 0.039 DBMET02958 0.135 0.005 DBMET02962 | DBMET02956 | |
| 0.415 | 0.046 | 0.656 | Cholesterol antagonist | 0.428 0.044 DBMET02956 0.638 0.014 DBMET02959 0.636 0.014 DBMET02960 0.387 0.052 DBMET02961 0.584 0.021 DBMET02963 0.656 0.012 DBMET02957 0.655 0.012 DBMET02958 0.296 0.094 DBMET02962 | DBMET02957 | |
| 0.435 | 0.073 | 0.749 | Cyclophilin D inhibitor | 0.487 0.054 DBMET02956 0.72 0.012 DBMET02959 0.573 0.033 DBMET02960 0.541 0.039 DBMET02961 0.453 0.066 DBMET02963 0.749 0.01 DBMET02957 0.745 0.01 DBMET02958 0.472 0.059 DBMET02962 | DBMET02957 | |
| 0.354 | 0.003 | 0.379 | Acetylcholine M5 receptor antagonist | 0.379 0.003 DBMET02956 0.141 0.009 DBMET02961 0.069 0.032 DBMET02963 | DBMET02956 | |
| 0.372 | 0.034 | 0.451 | Antiamyloidogenic | 0.323 0.045 DBMET02956 0.409 0.027 DBMET02959 0.436 0.023 DBMET02960 0.316 0.047 DBMET02961 0.451 0.021 DBMET02957 0.393 0.03 DBMET02958 | DBMET02957 | |
| 0.379 | 0.043 | 0.592 | Vasodilator, coronary | 0.339 0.061 DBMET02956 0.592 0.008 DBMET02959 0.477 0.019 DBMET02960 0.534 0.012 DBMET02961 0.506 0.015 DBMET02957 0.541 0.011 DBMET02958 0.301 0.087 DBMET02962 | DBMET02959 | |
| 0.338 | 0.002 | 0.463 | Beta 3 adrenoreceptor antagonist | 0.344 0.002 DBMET02956 0.463 0.002 DBMET02961 0.139 0.007 DBMET02963 0.061 0.052 DBMET02957 0.202 0.004 DBMET02962 | DBMET02961 | |
| 0.398 | 0.078 | 0.698 | Antibacterial | 0.448 0.058 DBMET02956 0.667 0.011 DBMET02959 0.688 0.01 DBMET02960 0.227 0.2 DBMET02961 0.475 0.048 DBMET02963 0.698 0.009 DBMET02957 0.692 0.009 DBMET02958 0.323 0.119 DBMET02962 | DBMET02957 | |
| 0.35 | 0.031 | 0.603 | Psychostimulant | 0.369 0.028 DBMET02956 0.386 0.025 DBMET02959 0.197 0.082 DBMET02960 0.603 0.006 DBMET02961 0.358 0.03 DBMET02957 0.401 0.022 DBMET02958 0.183 0.091 DBMET02962 | DBMET02961 | |
| 0.363 | 0.053 | 0.684 | 5 Hydroxytryptamine release stimulant | 0.41 0.044 DBMET02956 0.251 0.088 DBMET02959 0.224 0.103 DBMET02960 0.684 0.008 DBMET02961 0.225 0.103 DBMET02957 0.288 0.074 DBMET02958 0.304 0.069 DBMET02962 | DBMET02961 | |
| 0.327 | 0.056 | 0.337 | Sodium/bile acid cotransporter inhibitor | 0.337 0.048 DBMET02956 0.259 0.119 DBMET02959 0.261 0.117 DBMET02960 0.329 0.054 DBMET02961 0.31 0.07 DBMET02963 0.285 0.093 DBMET02957 0.276 0.101 DBMET02958 0.278 0.1 DBMET02962 | DBMET02956 | |
| 0.263 | 0.017 | 0.638 | Anesthetic local | 0.259 0.018 DBMET02956 0.638 0.003 DBMET02961 0.124 0.064 DBMET02962 | DBMET02961 | |
| 0.282 | 0.064 | 0.348 | Cardiotonic | 0.29 0.061 DBMET02956 0.196 0.123 DBMET02959 0.348 0.04 DBMET02961 0.198 0.12 DBMET02957 0.186 0.134 DBMET02958 | DBMET02961 | |
| 0.218 | 0.028 | 0.248 | M18 aspartyl aminopeptidase inhibitor | 0.248 0.021 DBMET02956 0.21 0.03 DBMET02961 | DBMET02956 | |
| 0.26 | 0.072 | 0.369 | 5 Hydroxytryptamine uptake stimulant | 0.273 0.061 DBMET02956 0.369 0.021 DBMET02961 0.216 0.123 DBMET02962 | DBMET02961 | |
| 0.211 | 0.025 | 0.237 | DNA polymerase I inhibitor | 0.237 0.019 DBMET02956 0.213 0.024 DBMET02959 0.232 0.02 DBMET02960 0.163 0.042 DBMET02963 0.225 0.022 DBMET02957 0.234 0.02 DBMET02958 | DBMET02956 | |
| 0.193 | 0.016 | 0.572 | Mediator release inhibitor | 0.224 0.012 DBMET02956 0.391 0.005 DBMET02959 0.275 0.008 DBMET02960 0.139 0.034 DBMET02961 0.572 0.004 DBMET02957 0.485 0.004 DBMET02958 | DBMET02957 | |
| 0.236 | 0.062 | 0.376 | Peptidyltransferase inhibitor | 0.262 0.043 DBMET02956 0.359 0.011 DBMET02959 0.33 0.016 DBMET02960 0.269 0.039 DBMET02961 0.175 0.138 DBMET02963 0.372 0.009 DBMET02957 0.376 0.009 DBMET02958 0.213 0.083 DBMET02962 | DBMET02958 | |
| 0.183 | 0.037 | 0.516 | Monophenol monooxygenase inhibitor | 0.201 0.033 DBMET02956 0.428 0.01 DBMET02959 0.283 0.02 DBMET02960 0.148 0.048 DBMET02961 0.462 0.009 DBMET02957 0.516 0.007 DBMET02958 | DBMET02958 | |
| 0.21 | 0.064 | 0.284 | Insulin sensitizer | 0.208 0.065 DBMET02956 0.177 0.099 DBMET02959 0.284 0.02 DBMET02961 0.183 0.092 DBMET02957 0.178 0.098 DBMET02958 0.192 0.082 DBMET02962 | DBMET02961 | |
| 0.233 | 0.087 | 0.563 | Hypoglycemic | 0.242 0.082 DBMET02956 0.53 0.013 DBMET02959 0.455 0.02 DBMET02960 0.247 0.079 DBMET02961 0.563 0.01 DBMET02957 0.551 0.011 DBMET02958 | DBMET02957 | |
| 0.159 | 0.017 | 0.18 | Aminoacyl-tRNA synthetase inhibitor | 0.18 0.013 DBMET02956 0.124 0.028 DBMET02959 0.1 0.045 DBMET02960 0.18 0.013 DBMET02961 0.127 0.027 DBMET02963 0.138 0.023 DBMET02957 0.136 0.023 DBMET02958 0.127 0.027 DBMET02962 | DBMET02961 | |
| 0.221 | 0.082 | 0.472 | Free radical scavenger | 0.235 0.075 DBMET02956 0.43 0.024 DBMET02959 0.415 0.026 DBMET02960 0.19 0.106 DBMET02961 0.148 0.147 DBMET02963 0.472 0.019 DBMET02957 0.466 0.02 DBMET02958 | DBMET02957 | |
| 0.169 | 0.036 | 0.234 | Adenylate cyclase stimulant | 0.192 0.018 DBMET02956 0.234 0.005 DBMET02961 0.16 0.047 DBMET02963 0.134 0.093 DBMET02957 0.143 0.075 DBMET02958 0.213 0.009 DBMET02962 | DBMET02961 | |
| 0.207 | 0.08 | 0.25 | Interleukin antagonist | 0.25 0.062 DBMET02956 0.19 0.09 DBMET02961 0.149 0.119 DBMET02957 | DBMET02956 | |
| 0.169 | 0.06 | 0.298 | Melanin inhibitor | 0.162 0.067 DBMET02956 0.286 0.024 DBMET02959 0.188 0.047 DBMET02960 0.147 0.086 DBMET02961 0.274 0.025 DBMET02957 0.298 0.022 DBMET02958 | DBMET02958 | |
| 0.152 | 0.044 | 0.285 | Adenylate cyclase inhibitor | 0.198 0.026 DBMET02956 0.285 0.015 DBMET02961 0.125 0.063 DBMET02957 0.118 0.069 DBMET02958 | DBMET02961 | |
| 0.236 | 0.135 | 0.402 | Interleukin 2 agonist | 0.278 0.091 DBMET02956 0.368 0.038 DBMET02959 0.402 0.027 DBMET02960 0.32 0.061 DBMET02961 0.394 0.029 DBMET02957 0.395 0.029 DBMET02958 0.2 0.19 DBMET02962 | DBMET02960 | |
| 0.149 | 0.049 | 0.356 | Cyclooxygenase 3 inhibitor | 0.141 0.056 DBMET02956 0.356 0.005 DBMET02959 0.23 0.011 DBMET02960 0.147 0.051 DBMET02961 0.341 0.005 DBMET02957 0.348 0.005 DBMET02958 | DBMET02959 | |
| 0.207 | 0.109 | 0.493 | Antioxidant | 0.223 0.1 DBMET02956 0.448 0.027 DBMET02959 0.42 0.032 DBMET02960 0.203 0.112 DBMET02961 0.24 0.089 DBMET02963 0.493 0.021 DBMET02957 0.489 0.021 DBMET02958 0.172 0.14 DBMET02962 | DBMET02957 | |
| 0.131 | 0.034 | 0.131 | Electron transport complex I inhibitor | 0.109 0.064 DBMET02956 0.122 0.045 DBMET02961 0.096 0.091 DBMET02962 | ||
| 0.2 | 0.105 | 0.352 | Vasodilator | 0.202 0.103 DBMET02956 0.296 0.049 DBMET02959 0.259 0.064 DBMET02960 0.352 0.033 DBMET02961 0.309 0.045 DBMET02957 0.307 0.046 DBMET02958 | DBMET02961 | |
| 0.136 | 0.046 | 0.136 | MAO A inhibitor | 0.131 0.047 DBMET02956 0.118 0.054 DBMET02961 | ||
| 0.143 | 0.064 | 0.143 | MAO inhibitor | 0.128 0.07 DBMET02956 0.103 0.087 DBMET02961 | ||
| 0.199 | 0.122 | 0.375 | Interleukin agonist | 0.237 0.089 DBMET02956 0.32 0.039 DBMET02959 0.266 0.068 DBMET02960 0.375 0.023 DBMET02961 0.344 0.031 DBMET02957 0.347 0.03 DBMET02958 | DBMET02961 | |
| 0.135 | 0.066 | 0.175 | Interleukin 4 antagonist | 0.148 0.051 DBMET02956 0.148 0.052 DBMET02960 0.175 0.032 DBMET02961 0.147 0.053 DBMET02957 0.112 0.098 DBMET02958 | DBMET02961 | |
| 0.152 | 0.086 | 0.224 | Interleukin 6 antagonist | 0.154 0.083 DBMET02956 0.215 0.033 DBMET02959 0.158 0.078 DBMET02960 0.211 0.035 DBMET02957 0.224 0.03 DBMET02958 | DBMET02958 | |
| 0.118 | 0.056 | 0.205 | Mucolytic | 0.103 0.073 DBMET02956 0.119 0.056 DBMET02959 0.205 0.012 DBMET02961 0.098 0.081 DBMET02957 0.108 0.067 DBMET02958 | DBMET02961 | |
| 0.183 | 0.121 | 0.221 | Nitric-oxide synthase stimulant | 0.19 0.107 DBMET02956 0.193 0.101 DBMET02959 0.221 0.059 DBMET02961 0.187 0.113 DBMET02957 0.204 0.082 DBMET02958 | DBMET02961 | |
| 0.226 | 0.167 | 0.414 | Calpain 2 inhibitor | 0.253 0.148 DBMET02956 0.414 0.054 DBMET02961 | DBMET02961 | |
| 0.215 | 0.159 | 0.657 | Antithrombotic | 0.239 0.135 DBMET02956 0.638 0.013 DBMET02959 0.491 0.03 DBMET02960 0.245 0.13 DBMET02961 0.356 0.062 DBMET02963 0.631 0.013 DBMET02957 0.657 0.011 DBMET02958 0.257 0.121 DBMET02962 | DBMET02958 | |
| 0.067 | 0.013 | 0.083 | Alpha 1b adrenoreceptor agonist | 0.072 0.011 DBMET02956 0.083 0.007 DBMET02961 0.055 0.025 DBMET02962 | DBMET02961 | |
| 0.083 | 0.035 | 0.22 | Phenylalanine 4-hydroxylase inhibitor | 0.207 0.006 DBMET02956 0.22 0.006 DBMET02961 | DBMET02961 | |
| 0.097 | 0.05 | 0.097 | Calcium antagonist | 0.076 0.068 DBMET02961 | ||
| 0.055 | 0.01 | 0.06 | Aggrecanase 1 inhibitor | 0.06 0.009 DBMET02956 0.043 0.021 DBMET02963 | DBMET02956 | |
| 0.081 | 0.037 | 0.194 | Alpha adrenoreceptor agonist | 0.1 0.028 DBMET02956 0.194 0.009 DBMET02961 | DBMET02961 | |
| 0.085 | 0.046 | 0.11 | Somatostatin 1 agonist | 0.11 0.028 DBMET02956 0.106 0.03 DBMET02961 0.073 0.06 DBMET02958 0.073 0.06 DBMET02962 | DBMET02956 | |
| 0.102 | 0.063 | 0.132 | Gastric antisecretory | 0.092 0.076 DBMET02956 0.132 0.035 DBMET02963 | DBMET02963 | |
| 0.109 | 0.072 | 0.109 | Interleukin 1b antagonist | 0.093 0.09 DBMET02959 | ||
| 0.095 | 0.059 | 0.131 | Toll-Like receptor 3 antagonist | 0.131 0.022 DBMET02961 | DBMET02961 | |
| 0.19 | 0.155 | 0.259 | Tyrosine 3 hydroxylase inhibitor | 0.24 0.079 DBMET02956 0.259 0.06 DBMET02961 | DBMET02961 | |
| 0.25 | 0.228 | 0.36 | 5 Hydroxytryptamine release inhibitor | 0.277 0.192 DBMET02956 0.329 0.134 DBMET02959 0.332 0.131 DBMET02961 0.318 0.146 DBMET02957 0.36 0.106 DBMET02958 | DBMET02958 | |
| 0.187 | 0.169 | 0.421 | Hypoxia-inducible factor 1 alpha inhibitor | 0.184 0.172 DBMET02959 0.421 0.025 DBMET02961 0.194 0.159 DBMET02957 | DBMET02961 | |
| 0.02 | 0.004 | 0.021 | Antibiotic Tetracycline-like | 0.021 0.004 DBMET02956 0.017 0.007 DBMET02959 0.017 0.006 DBMET02960 0.016 0.009 DBMET02963 0.018 0.005 DBMET02957 0.018 0.005 DBMET02958 | DBMET02956 | |
| 0.092 | 0.078 | 0.275 | Expectorant | 0.275 0.01 DBMET02959 0.151 0.035 DBMET02960 0.212 0.018 DBMET02961 0.223 0.016 DBMET02957 0.248 0.013 DBMET02958 | DBMET02959 | |
| 0.028 | 0.019 | 0.039 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET02956 0.031 0.013 DBMET02959 0.029 0.018 DBMET02960 0.03 0.015 DBMET02961 0.037 0.005 DBMET02963 0.033 0.009 DBMET02957 0.033 0.009 DBMET02958 0.039 0.004 DBMET02962 | DBMET02962 | |
| 0.023 | 0.015 | 0.036 | Alpha 1a adrenoreceptor agonist | 0.025 0.014 DBMET02956 0.036 0.008 DBMET02961 | DBMET02961 | |
| 0.099 | 0.092 | 0.121 | Beta amyloid protein antagonist | 0.121 0.067 DBMET02959 0.107 0.081 DBMET02960 0.101 0.088 DBMET02957 | DBMET02959 | |
| 0.023 | 0.017 | 0.068 | Protein 30S ribosomal subunit inhibitor | 0.027 0.014 DBMET02956 0.062 0.006 DBMET02959 0.055 0.007 DBMET02960 0.066 0.005 DBMET02957 0.068 0.005 DBMET02958 | DBMET02958 | |
| 0.113 | 0.107 | 0.417 | Peroxidase inhibitor | 0.24 0.05 DBMET02956 0.417 0.018 DBMET02961 | DBMET02961 | |
| 0.054 | 0.05 | 0.065 | Cathepsin E inhibitor | 0.054 0.051 DBMET02956 0.065 0.034 DBMET02961 0.054 0.051 DBMET02962 | DBMET02961 | |
| 0.099 | 0.098 | 0.127 | Interleukin 8 antagonist | 0.127 0.053 DBMET02956 | DBMET02956 | |
| 0.126 | 0.125 | 0.293 | Nitric oxide antagonist | 0.277 0.045 DBMET02959 0.267 0.047 DBMET02960 0.292 0.042 DBMET02957 0.293 0.042 DBMET02958 | DBMET02958 | |
| 0.058 | 0.059 | 0.172 | Neuraminidase (influenza) inhibitor | 0.067 0.04 DBMET02956 0.075 0.03 DBMET02959 0.073 0.031 DBMET02960 0.06 0.053 DBMET02961 0.074 0.03 DBMET02963 0.094 0.018 DBMET02957 0.088 0.02 DBMET02958 0.172 0.005 DBMET02962 | DBMET02962 | |
| 0.161 | 0.162 | 0.26 | Calpain inhibitor | 0.183 0.131 DBMET02956 0.26 0.056 DBMET02961 | DBMET02961 | |
| 0.05 | 0.052 | 0.09 | Alpha 1 adrenoreceptor agonist | 0.09 0.019 DBMET02961 | DBMET02961 | |
| 0.032 | 0.034 | 0.067 | Antibiotic Aminoglycoside-like | 0.065 0.007 DBMET02959 0.059 0.009 DBMET02960 0.067 0.007 DBMET02957 0.067 0.007 DBMET02958 | DBMET02958 | |
| 0.011 | 0.017 | 0.015 | Calcium-sensing receptor antagonist | 0.015 0.011 DBMET02961 | DBMET02961 | |
| 0.084 | 0.09 | 0.118 | Anabolic | 0.113 0.046 DBMET02956 0.118 0.041 DBMET02961 0.106 0.055 DBMET02963 0.101 0.061 DBMET02962 | DBMET02961 | |
| 0.164 | 0.178 | 0.342 | DNA synthesis inhibitor | 0.202 0.12 DBMET02956 0.295 0.045 DBMET02959 0.261 0.06 DBMET02960 0.319 0.038 DBMET02957 0.342 0.032 DBMET02958 | DBMET02958 | |
| 0.075 | 0.09 | 0.111 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 DBMET02959 0.092 0.052 DBMET02960 0.106 0.032 DBMET02957 0.106 0.032 DBMET02958 | DBMET02959 | |
| 0.047 | 0.062 | 0.116 | Neuraminidase inhibitor | 0.059 0.044 DBMET02956 0.07 0.034 DBMET02959 0.065 0.038 DBMET02960 0.06 0.044 DBMET02963 0.085 0.022 DBMET02957 0.082 0.024 DBMET02958 0.116 0.011 DBMET02962 | DBMET02962 | |
| 0.073 | 0.093 | 0.102 | Interleukin 5 antagonist | 0.102 0.039 DBMET02961 0.081 0.072 DBMET02957 | DBMET02961 | |
| 0.095 | 0.117 | 0.114 | Cathepsin H inhibitor | 0.114 0.083 DBMET02956 | DBMET02956 | |
| 0.112 | 0.134 | 0.139 | Growth hormone agonist | 0.124 0.115 DBMET02956 0.139 0.097 DBMET02961 | DBMET02961 | |
| 0.014 | 0.036 | 0.028 | Sigma 1 receptor antagonist | 0.028 0.018 DBMET02961 | DBMET02961 | |
| 0.071 | 0.097 | 0.098 | Protease inhibitor | 0.098 0.067 DBMET02961 | DBMET02961 | |
| 0.106 | 0.136 | 0.141 | Phospholipase A2 inhibitor | 0.141 0.085 DBMET02961 | DBMET02961 | |
| 0.038 | 0.068 | 0.058 | Cathepsin D inhibitor | 0.058 0.035 DBMET02961 | DBMET02961 | |
| 0.085 | 0.115 | 0.098 | Factor V inhibitor | 0.098 0.074 DBMET02961 | DBMET02961 | |
| 0.141 | 0.171 | 0.325 | Tumour necrosis factor alpha release inhibitor | 0.325 0.045 DBMET02959 0.294 0.055 DBMET02960 0.315 0.048 DBMET02957 0.301 0.053 DBMET02958 | DBMET02959 | |
| 0.175 | 0.206 | 0.399 | Vasodilator, peripheral | 0.399 0.055 DBMET02961 | DBMET02961 | |
| 0.028 | 0.062 | 0.045 | HIV-1 protease inhibitor | 0.045 0.028 DBMET02962 | DBMET02962 | |
| 0.036 | 0.07 | 0.069 | Maillard reaction inhibitor | 0.069 0.029 DBMET02961 | DBMET02961 | |
| 0.03 | 0.066 | 0.061 | Plasmepsin II inhibitor | 0.061 0.011 DBMET02961 | DBMET02961 | |
| 0.04 | 0.08 | 0.073 | Carbonic anhydrase stimulant | 0.053 0.049 DBMET02956 0.073 0.03 DBMET02961 | DBMET02961 | |
| 0.035 | 0.075 | 0.062 | Opioid delta receptor antagonist | 0.062 0.045 DBMET02956 | DBMET02956 | |
| 0.061 | 0.104 | 0.086 | Opioid antagonist | 0.086 0.061 DBMET02956 | DBMET02956 | |
| 0.067 | 0.111 | 0.128 | Sphingomyelinase inhibitor | 0.128 0.036 DBMET02961 | DBMET02961 | |
| 0.177 | 0.222 | 0.41 | Immunosuppressant | 0.399 0.063 DBMET02959 0.403 0.062 DBMET02960 0.226 0.17 DBMET02961 0.41 0.059 DBMET02957 0.408 0.06 DBMET02958 | DBMET02957 | |
| 0.037 | 0.094 | 0.059 | Opioid mu receptor antagonist | 0.059 0.055 DBMET02956 | DBMET02956 | |
| 0.026 | 0.087 | 0.064 | Beta tubulin antagonist | 0.064 0.037 DBMET02961 | DBMET02961 | |
| 0.117 | 0.179 | 0.234 | Hypolipemic | 0.222 0.081 DBMET02959 0.151 0.135 DBMET02960 0.234 0.075 DBMET02957 0.234 0.075 DBMET02958 | DBMET02958 | |
| 0.005 | 0.068 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 DBMET02959 | DBMET02959 | |
| 0.092 | 0.158 | 0.29 | Cell wall synthesis inhibitor | 0.143 0.072 DBMET02956 0.225 0.022 DBMET02959 0.175 0.044 DBMET02960 0.199 0.03 DBMET02963 0.29 0.01 DBMET02957 0.283 0.011 DBMET02958 0.151 0.064 DBMET02962 | DBMET02957 | |
| 0.051 | 0.117 | 0.085 | Alpha adrenoreceptor antagonist | 0.085 0.067 DBMET02961 | DBMET02961 | |
| 0.011 | 0.078 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET02960 0.018 0.017 DBMET02961 | DBMET02960 | |
| 0.026 | 0.096 | 0.075 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET02959 0.041 0.04 DBMET02960 0.048 0.028 DBMET02957 0.048 0.026 DBMET02958 0.075 0.005 DBMET02962 | DBMET02962 | |
| 0.071 | 0.141 | 0.112 | Nav1.4 sodium channel blocker | 0.091 0.09 DBMET02956 0.098 0.079 DBMET02961 0.112 0.06 DBMET02963 | DBMET02963 | |
| 0.179 | 0.249 | 0.339 | Calcium channel activator | 0.339 0.058 DBMET02961 | DBMET02961 | |
| 0.035 | 0.108 | 0.137 | Antineoplastic antibiotic | 0.126 0.037 DBMET02959 0.133 0.035 DBMET02960 0.133 0.035 DBMET02957 0.137 0.034 DBMET02958 | DBMET02958 | |
| 0.035 | 0.118 | 0.047 | Factor III inhibitor | 0.047 0.044 DBMET02959 0.047 0.042 DBMET02958 | DBMET02958 | |
| 0.04 | 0.123 | 0.078 | Glutamate decarboxylase inhibitor | 0.078 0.046 DBMET02956 0.068 0.058 DBMET02961 | DBMET02956 | |
| 0.043 | 0.136 | 0.087 | Secretase beta inhibitor | 0.087 0.028 DBMET02961 | DBMET02961 | |
| 0.059 | 0.153 | 0.109 | Transcription factor NF kappa B stimulant | 0.107 0.033 DBMET02959 0.106 0.034 DBMET02960 0.109 0.031 DBMET02957 0.108 0.032 DBMET02958 | DBMET02957 | |
| 0.063 | 0.16 | 0.086 | Estrogen-related receptor beta agonist | 0.086 0.05 DBMET02961 | DBMET02961 | |
| 0.106 | 0.208 | 0.449 | Immunostimulant | 0.158 0.148 DBMET02956 0.401 0.049 DBMET02959 0.365 0.06 DBMET02960 0.239 0.101 DBMET02961 0.19 0.126 DBMET02963 0.44 0.039 DBMET02957 0.449 0.037 DBMET02958 0.195 0.123 DBMET02962 | DBMET02958 | |
| 0.007 | 0.109 | 0.216 | Cholecystokinin A antagonist | 0.216 0.004 DBMET02963 0.067 0.015 DBMET02962 | DBMET02963 | |
| 0.07 | 0.174 | 0.197 | Lipid peroxidase inhibitor | 0.161 0.061 DBMET02959 0.165 0.059 DBMET02960 0.197 0.043 DBMET02957 0.184 0.048 DBMET02958 | DBMET02957 | |
| 0.063 | 0.169 | 0.146 | Carbonic anhydrase XV inhibitor | 0.146 0.032 DBMET02961 | DBMET02961 | |
| 0.092 | 0.202 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.101 DBMET02961 | DBMET02961 | |
| 0.037 | 0.152 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 DBMET02960 0.057 0.034 DBMET02963 0.054 0.044 DBMET02957 0.054 0.044 DBMET02958 | DBMET02960 | |
| 0.027 | 0.143 | 0.071 | Alpha 2 adrenoreceptor agonist | 0.071 0.03 DBMET02961 | DBMET02961 | |
| 0.017 | 0.143 | 0.403 | Cholecystokinin B agonist | 0.403 0.003 DBMET02963 0.114 0.005 DBMET02962 | DBMET02963 | |
| 0.031 | 0.157 | 0.088 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET02959 0.08 0.05 DBMET02957 0.088 0.042 DBMET02958 | DBMET02958 | |
| 0.034 | 0.161 | 0.067 | Aminopeptidase I inhibitor | 0.067 0.058 DBMET02956 | DBMET02956 | |
| 0.023 | 0.152 | 0.293 | Selectin antagonist | 0.277 0.007 DBMET02959 0.231 0.009 DBMET02960 0.102 0.027 DBMET02963 0.288 0.006 DBMET02957 0.293 0.006 DBMET02958 0.162 0.016 DBMET02962 | DBMET02958 | |
| 0.056 | 0.187 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.049 DBMET02961 | DBMET02961 | |
| 0.009 | 0.145 | 0.038 | Diamine oxidase inhibitor | 0.038 0.026 DBMET02961 | DBMET02961 | |
| 0.027 | 0.166 | 0.111 | Factor IXa inhibitor | 0.056 0.03 DBMET02959 0.049 0.038 DBMET02960 0.072 0.019 DBMET02963 0.066 0.023 DBMET02957 0.061 0.026 DBMET02958 0.111 0.008 DBMET02962 | DBMET02962 | |
| 0.005 | 0.146 | 0.115 | Cholecystokinin B antagonist | 0.115 0.005 DBMET02963 0.03 0.022 DBMET02962 | DBMET02963 | |
| 0.07 | 0.212 | 0.152 | Amyloid beta aggregation inhibitor | 0.152 0.107 DBMET02961 | DBMET02961 | |
| 0.049 | 0.191 | 0.1 | Cholesterol synthesis inhibitor | 0.1 0.088 DBMET02962 | DBMET02962 | |
| 0.053 | 0.196 | 0.107 | Carbonic anhydrase III inhibitor | 0.107 0.055 DBMET02961 | DBMET02961 | |
| 0.107 | 0.254 | 0.21 | Cyclic AMP phosphodiesterase inhibitor | 0.21 0.087 DBMET02959 0.204 0.091 DBMET02961 0.169 0.123 DBMET02957 0.204 0.09 DBMET02958 | DBMET02959 | |
| 0.016 | 0.164 | 0.072 | Alpha tubulin antagonist | 0.064 0.028 DBMET02961 0.049 0.042 DBMET02963 0.072 0.023 DBMET02962 | DBMET02962 | |
| 0.067 | 0.215 | 0.478 | Angiogenesis stimulant | 0.449 0.015 DBMET02959 0.427 0.018 DBMET02960 0.213 0.088 DBMET02961 0.308 0.046 DBMET02963 0.473 0.013 DBMET02957 0.478 0.013 DBMET02958 0.371 0.027 DBMET02962 | DBMET02958 | |
| 0.007 | 0.155 | 0.152 | Cholecystokinin antagonist | 0.152 0.005 DBMET02963 0.051 0.024 DBMET02962 | DBMET02963 | |
| 0.145 | 0.298 | 0.354 | Histamine release inhibitor | 0.354 0.098 DBMET02961 0.265 0.144 DBMET02957 0.235 0.168 DBMET02958 | DBMET02961 | |
| 0.049 | 0.203 | 0.147 | Tubulin antagonist | 0.147 0.059 DBMET02961 | DBMET02961 | |
| 0.015 | 0.17 | 0.065 | Leukocyte elastase inhibitor | 0.065 0.016 DBMET02963 | DBMET02963 | |
| 0.036 | 0.194 | 0.155 | Topoisomerase I inhibitor | 0.137 0.047 DBMET02959 0.121 0.055 DBMET02960 0.134 0.048 DBMET02957 0.155 0.039 DBMET02958 | DBMET02958 | |
| 0.019 | 0.179 | 0.061 | Elastase inhibitor | 0.061 0.029 DBMET02963 0.05 0.041 DBMET02962 | DBMET02963 | |
| 0.012 | 0.177 | 0.053 | Phosphorylase inhibitor | 0.048 0.031 DBMET02957 0.053 0.029 DBMET02958 | DBMET02958 | |
| 0.018 | 0.185 | 0.072 | Protein 50S ribosomal subunit inhibitor | 0.072 0.023 DBMET02959 0.064 0.028 DBMET02960 0.071 0.023 DBMET02957 0.071 0.023 DBMET02958 | DBMET02959 | |
| 0.02 | 0.191 | 0.052 | Alpha-mannosidase inhibitor | 0.049 0.046 DBMET02959 0.052 0.039 DBMET02957 0.052 0.04 DBMET02958 | DBMET02958 | |
| 0.044 | 0.218 | 0.198 | Alpha 2b adrenoreceptor antagonist | 0.198 0.024 DBMET02961 | DBMET02961 | |
| 0.103 | 0.277 | 0.157 | Neurotensin receptor agonist | 0.157 0.085 DBMET02961 | DBMET02961 | |
| 0.079 | 0.256 | 0.123 | Vanilloid 1 agonist | 0.117 0.096 DBMET02961 0.123 0.081 DBMET02962 | DBMET02962 | |
| 0.015 | 0.195 | 0.072 | Alpha 1b adrenoreceptor antagonist | 0.072 0.052 DBMET02961 | DBMET02961 | |
| 0.014 | 0.196 | 0.044 | Mannosidase inhibitor | 0.044 0.034 DBMET02957 0.043 0.035 DBMET02958 | DBMET02957 | |
| 0.027 | 0.219 | 0.07 | Thrombin inhibitor | 0.07 0.055 DBMET02963 0.069 0.057 DBMET02962 | DBMET02963 | |
| 0.05 | 0.244 | 0.111 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.087 DBMET02957 0.111 0.087 DBMET02958 | DBMET02958 | |
| 0.045 | 0.241 | 0.144 | Nav1.3 sodium channel blocker | 0.144 0.052 DBMET02961 | DBMET02961 | |
| 0.051 | 0.25 | 0.08 | Vanilloid agonist | 0.08 0.072 DBMET02962 | DBMET02962 | |
| 0.064 | 0.272 | 0.275 | Anesthetic general | 0.275 0.04 DBMET02961 | DBMET02961 | |
| 0.055 | 0.267 | 0.156 | Cell adhesion inhibitor | 0.146 0.049 DBMET02959 0.143 0.051 DBMET02960 0.156 0.043 DBMET02957 0.139 0.053 DBMET02958 0.136 0.055 DBMET02962 | DBMET02957 | |
| 0.017 | 0.234 | 0.069 | Dopamine agonist | 0.069 0.045 DBMET02962 | DBMET02962 | |
| 0.087 | 0.305 | 0.189 | Phospholipase C inhibitor | 0.189 0.052 DBMET02961 | DBMET02961 | |
| 0.069 | 0.288 | 0.296 | Hepatoprotectant | 0.286 0.034 DBMET02959 0.27 0.038 DBMET02960 0.29 0.033 DBMET02957 0.296 0.031 DBMET02958 0.152 0.107 DBMET02962 | DBMET02958 | |
| 0.1 | 0.327 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.153 0.143 DBMET02961 | DBMET02961 | |
| 0.022 | 0.251 | 0.055 | Glucose-6-phosphate translocase inhibitor | 0.055 0.03 DBMET02959 0.049 0.041 DBMET02960 0.051 0.036 DBMET02957 0.053 0.033 DBMET02958 | DBMET02959 | |
| 0.053 | 0.284 | 0.286 | Anticoagulant | 0.162 0.07 DBMET02959 0.2 0.053 DBMET02960 0.279 0.032 DBMET02963 0.181 0.061 DBMET02957 0.176 0.063 DBMET02958 0.286 0.031 DBMET02962 | DBMET02962 | |
| 0.09 | 0.327 | 0.193 | Superoxide dismutase inhibitor | 0.193 0.125 DBMET02961 | DBMET02961 | |
| 0.008 | 0.245 | 0.032 | NMDA 2D receptor antagonist | 0.032 0.014 DBMET02963 | DBMET02963 | |
| 0.046 | 0.289 | 0.132 | Toll-Like receptor 4 antagonist | 0.13 0.034 DBMET02959 0.125 0.039 DBMET02960 0.097 0.075 DBMET02961 0.114 0.05 DBMET02957 0.132 0.033 DBMET02958 | DBMET02958 | |
| 0.042 | 0.288 | 0.108 | Bone formation stimulant | 0.108 0.097 DBMET02962 | DBMET02962 | |
| 0.014 | 0.261 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.021 DBMET02959 0.025 0.023 DBMET02960 0.025 0.024 DBMET02963 | DBMET02963 | |
| 0.004 | 0.252 | 0.214 | Cholecystokinin agonist | 0.214 0.003 DBMET02963 0.095 0.004 DBMET02962 | DBMET02963 | |
| 0.073 | 0.322 | 0.142 | Interferon gamma antagonist | 0.128 0.116 DBMET02959 0.142 0.09 DBMET02960 0.135 0.1 DBMET02957 0.139 0.095 DBMET02958 | DBMET02960 | |
| 0.03 | 0.281 | 0.105 | DNA intercalator | 0.105 0.068 DBMET02963 | DBMET02963 | |
| 0.023 | 0.28 | 0.073 | Cathepsin G inhibitor | 0.073 0.05 DBMET02962 | DBMET02962 | |
| 0.02 | 0.288 | 0.068 | Heparanase inhibitor | 0.068 0.013 DBMET02959 0.062 0.02 DBMET02960 0.064 0.017 DBMET02957 0.064 0.018 DBMET02958 | DBMET02959 | |
| 0.064 | 0.333 | 0.164 | Insulin secretagoues | 0.16 0.065 DBMET02959 0.124 0.105 DBMET02960 0.159 0.065 DBMET02957 0.164 0.061 DBMET02958 | DBMET02958 | |
| 0.113 | 0.389 | 0.258 | Caspase 3 stimulant | 0.258 0.105 DBMET02960 | DBMET02960 | |
| 0.047 | 0.323 | 0.124 | Protein kinase stimulant | 0.124 0.088 DBMET02961 | DBMET02961 | |
| 0.004 | 0.295 | 0.174 | Cholecystokinin A agonist | 0.174 0.003 DBMET02963 0.065 0.004 DBMET02962 | DBMET02963 | |
| 0.027 | 0.319 | 0.131 | Topoisomerase II inhibitor | 0.115 0.071 DBMET02959 0.111 0.076 DBMET02957 0.131 0.059 DBMET02958 | DBMET02958 | |
| 0.03 | 0.334 | 0.103 | Cell adhesion molecule inhibitor | 0.103 0.033 DBMET02962 | DBMET02962 | |
| 0.032 | 0.34 | 0.221 | Thrombolytic | 0.205 0.049 DBMET02959 0.161 0.073 DBMET02960 0.202 0.051 DBMET02957 0.221 0.042 DBMET02958 0.144 0.086 DBMET02962 | DBMET02958 | |
| 0.016 | 0.324 | 0.097 | Protein-tyrosine phosphatase 1B inhibitor | 0.097 0.082 DBMET02963 | DBMET02963 | |
| 0.017 | 0.326 | 0.069 | CDC25A inhibitor | 0.069 0.059 DBMET02963 | DBMET02963 | |
| 0.019 | 0.334 | 0.079 | Topoisomerase II alpha inhibitor | 0.079 0.054 DBMET02958 | DBMET02958 | |
| 0.05 | 0.366 | 0.142 | Antimitotic | 0.142 0.13 DBMET02961 | DBMET02961 | |
| 0.115 | 0.432 | 0.387 | Apoptosis agonist | 0.385 0.121 DBMET02959 0.379 0.124 DBMET02960 0.247 0.217 DBMET02961 0.358 0.135 DBMET02957 0.387 0.12 DBMET02958 | DBMET02958 | |
| 0.033 | 0.364 | 0.106 | Amylase inhibitor | 0.106 0.091 DBMET02958 | DBMET02958 | |
| 0.023 | 0.355 | 0.105 | Alkylator | 0.095 0.094 DBMET02959 0.096 0.093 DBMET02961 0.105 0.082 DBMET02958 | DBMET02958 | |
| 0.013 | 0.363 | 0.079 | DNA gyrase inhibitor | 0.079 0.027 DBMET02960 | DBMET02960 | |
| 0.042 | 0.407 | 0.229 | Platelet antagonist | 0.183 0.114 DBMET02959 0.229 0.082 DBMET02960 0.163 0.132 DBMET02957 0.187 0.111 DBMET02958 | DBMET02960 | |
| 0.058 | 0.424 | 0.159 | ATPase inhibitor | 0.156 0.092 DBMET02959 0.145 0.111 DBMET02957 0.159 0.087 DBMET02958 | DBMET02958 | |
| 0.037 | 0.419 | 0.117 | Nav1.2 sodium channel blocker | 0.117 0.087 DBMET02961 | DBMET02961 | |
| 0.087 | 0.472 | 0.281 | Apoptosis antagonist | 0.263 0.115 DBMET02959 0.267 0.111 DBMET02960 0.281 0.099 DBMET02957 0.276 0.103 DBMET02958 | DBMET02957 | |
| 0.003 | 0.399 | 0.02 | Estrone sulfatase inhibitor | 0.02 0.018 DBMET02962 | DBMET02962 | |
| 0.031 | 0.437 | 0.141 | Dual specificity phosphatase inhibitor | 0.141 0.105 DBMET02963 | DBMET02963 | |
| 0.02 | 0.451 | 0.167 | Protein-tyrosine phosphatase inhibitor | 0.167 0.064 DBMET02963 | DBMET02963 | |
| 0.029 | 0.546 | 0.177 | Hemostatic | 0.151 0.067 DBMET02959 0.136 0.087 DBMET02963 0.176 0.045 DBMET02957 0.177 0.044 DBMET02958 0.134 0.089 DBMET02962 | DBMET02958 | |
| 0.029 | 0.575 | 0.192 | Platelet adhesion inhibitor | 0.189 0.077 DBMET02959 0.165 0.091 DBMET02960 0.184 0.08 DBMET02957 0.192 0.075 DBMET02958 | DBMET02958 | |
| 0.017 | 0.578 | 0.11 | Multidrug resistance-associated protein 1 inhibitor | 0.11 0.062 DBMET02963 | DBMET02963 | |
| 0.015 | 0.579 | 0.073 | Sodium/calcium exchanger inhibitor | 0.073 0.011 DBMET02961 | DBMET02961 | |
| 0.005 | 0.595 | 0.058 | NMDA 2B receptor antagonist | 0.058 0.032 DBMET02963 | DBMET02963 | |
| 0.016 | 0.677 | 0.081 | Thioredoxin inhibitor | 0.081 0.079 DBMET02958 | DBMET02958 | |
| 0.037 | 0.737 | 0.539 | Antiinflammatory | 0.499 0.088 DBMET02959 0.42 0.127 DBMET02960 0.463 0.104 DBMET02957 0.539 0.072 DBMET02958 | DBMET02958 | |
| 0.025 | 0.755 | 0.189 | Immunomodulator | 0.189 0.178 DBMET02957 0.187 0.18 DBMET02958 | DBMET02957 | |
| 0.029 | 0.774 | 0.127 | NOS3 expression enhancer | 0.127 0.103 DBMET02958 | DBMET02958 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |